Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Castagna

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Transplantation|May 15, 1997
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host diseaseG Carayol, J H Bourhis, M Guillard, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|April 5, 2016
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myelomaM Martino, R M Lemoli, C Girmenia, et al.
Bone Marrow Transplantation|August 31, 2002
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomasL Castagna, A Bertuzzi, A Nozza, et al.
Bone Marrow Transplantation|June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation|March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation|June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphomaR Crocchiolo, L Castagna, S Fürst, et al.
British Journal of Cancer|October 2, 2003
Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumourA Bertuzzi, L Castagna, V Quagliuolo, et al.
Epidemiology and Infection|July 15, 2014
Evaluation of PCR in the diagnosis of canine leishmaniasis in two different epidemiological regions: Campinas (SP) and Teresina (PI), BrazilL N G Costa, A S Borba, C L Castagna, et al.
Bone Marrow Transplantation|November 5, 2013
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphomaA Raiola, A Dominietto, R Varaldo, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Transplantation|May 15, 1997
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host diseaseG Carayol, J H Bourhis, M Guillard, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|April 5, 2016
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myelomaM Martino, R M Lemoli, C Girmenia, et al.
Bone Marrow Transplantation|August 31, 2002
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomasL Castagna, A Bertuzzi, A Nozza, et al.
Bone Marrow Transplantation|June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation|March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation|June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphomaR Crocchiolo, L Castagna, S Fürst, et al.
British Journal of Cancer|October 2, 2003
Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumourA Bertuzzi, L Castagna, V Quagliuolo, et al.
Epidemiology and Infection|July 15, 2014
Evaluation of PCR in the diagnosis of canine leishmaniasis in two different epidemiological regions: Campinas (SP) and Teresina (PI), BrazilL N G Costa, A S Borba, C L Castagna, et al.
Bone Marrow Transplantation|November 5, 2013
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphomaA Raiola, A Dominietto, R Varaldo, et al.
Pageof 10